News Column

$2 Million Funding Available for Next-Gen Rapid Testing and Point-of-Care Diagnosis for Oral Pathogens

July 29, 2014

by MARY GRACE DEJUCOS Targeted News Service

WASHINGTON, July 29 -- The U.S. National Institutes of Health has announced that it expects to award a discretionary grant to encourage research on developing the next-generation of rapid tests and point-of-care diagnostic devices.

This funding opportunity uses the Small Business Technology Transfer (STTR) Grant mechanism (R41/R42).

The estimated total program funding available was cited as $2 million.

This funding opportunity is open to small businesses.

A funding opportunity notice from NIH states: "The goal of this STTR Funding Opportunity Announcement (FOA) is to encourage research to develop the next-generation of rapid tests and point-of-care (POC) diagnostic devices.These tools must use oral biospecimens for detecting oral pathogens and biomarkers of associated oral diseases to facilitate their screening, monitoring and diagnosis.The ultimate goal is to produce highly reliable, reproducible, specific and sensitive tools for early detection and diagnosis of oral diseases, including those associated with HIV/AIDS.These methods must demonstrate superior technical performance compared with current technologies while not increasing costs and minimizing the invasiveness of specimen collection from patients."

The funding opportunity number is RFA-DE-15-001 (CFDA 93.121). The application closing date is Nov. 20.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, 703/304-1897;; To subscribe to our Federal Grant Opportunities Newsletters, contact Dona Harms at:

18DejucosGrace 140728-db-1170197

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Targeted News Service

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters